Skip to main content
Watch Insiders

Corporate insider profile

Jason V Coloma Insider Trades

Latest reported as Chief Executive Officer of Maze Therapeutics, Inc. (MAZE).

Purchase filings
0
Reported companies
1
Net open-market value
-$6,186,762.03
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

MAZELatest reported

Maze Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale34,501$27.02$932,258
Sep 3, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale22,638$26.24$593,955
Sep 1, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale34,501$26.29$907,000
Aug 3, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale34,501$26.73$922,315
Jul 1, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale34,501$29.98$1,034,254
Jun 23, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale27,858$26.04$725,495
Jun 1, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale6,643$26.20$174,048
May 26, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale32,564$26.01$847,048
May 15, 2026Maze Therapeutics, Inc. (MAZE)Chief Executive OfficerSale1,938$26.00$50,388